Publications

See Dr. Pang's publications on PubMed

  • Insect Acetylcholinesterase as a Target for Effective and Environmentally-Safe Insecticides, Yuan-Ping Pang, Target Receptor in the Control of Insect Pests, Part II, Book Series: Advances in Insect Physiology, Volume 46 (2014).
  • Common Pharmacophore of Structurally Distinct Small-Molecule Inhibitors of Intracellular Retrograde Trafficking of Ribosome Inactivating Proteins, Shichao Yu, Jewn Giew Park, Jennifer Nielsen Kahn, Nilgun E. Tumer, and Yuan-Ping Pang, Sci. Rep., 3, 3397, DOI:10.1038/srep03397 (2013).
  • Novel Selective and Irreversible Mosquito Acetylcholinesterase Inhibitors for Controlling Malaria and Other Mosquito-Borne Diseases, Dengfeng Dou, Jewn Giew Park, Sandeep Rana, Benjamin J. Madden, Haobo Jiang, and Yuan-Ping Pang, Sci. Rep. 3, 1068; DOI:10.1038/srep01068 (2013).
  • Chemical Structure of Retro-2, a Compound That Protects Cells against Ribosome-Inactivating Proteins, Jewn Giew Park, Jennifer Nielsen Kahn, Nilgun E. Tumer, Yuan-Ping Pang, Sci. Rep., 631, doi:10.1038/srep00631 (2012).
  • Novel and Viable Acetylcholinesterase Target Site for Developing Effective and Environmentally Safe Insecticides, Yuan-Ping Pang, Stephen Brimijoin, David W. Ragsdale, Kun Yan Zhu, and Robert Suranyi, Current Drug Targets, 13, 471-482 (2012), PMID22280344, Open Access.
  • Cholinergic and Non-Cholinergic Functions of Two Acetylcholinesterase Genes Revealed by Gene-Silencing in Tribolium castaneum, Yanhui Lu, Yoonseong Park, Xiwu Gao, Xin Zhang, Jianxiu Yao, Yuan-Ping Pang, Haobo Jiang, Kun Yan Zhu, Sci. Rep., 2, 288, doi:10.1038/srep00288 (2012).
  • Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization, Yuan-Ping Pang, Haiming Dai, Alyson Smith, X. Wei Meng, Paula A. Schneider, Scott H. Kaufmann, Sci. Rep., 2, 257; DOI:10.1038/srep00257 (2012).
  • Genome Organization, Phylogenies, Expression Patterns, and Three-Dimensional Protein Models of Two Acetylcholinesterase Genes from the Red Flour Beetle, Yanhui Lu, Yuan-Ping Pang, Yoonseong Park, Xiwu Gao, Jianxiu Yao, Xin Zhang, Kun Yan Zhu, PLoS ONE, 7(2): e32288 (2012).
  • Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. Dai H, Smith A, Meng XW, Schneider PA, Pang YP, Kaufmann SH, J. Cell Biol., 194, 39-48 (2011).
  • Small-Molecule Inhibitor Leads of Ribosome-Inactivating Proteins Developed Using the Doorstop Approach. Yuan-Ping Pang, Jewn Giew Park, Shaohua Wang, Anuradha Vummenthala, Rajesh K. Mishra, John E. McLaughlin, Rong Di, Jennifer Nielsen Kahn, Nilgun E. Tumer, Laszlo Janosi, Jon Davis, and Charles B. Millard, PLoS ONE, 5(4): e17883 (2011)
  • Small Molecules Showing Significant Protection of Mice against Botulinum Neurotoxin Serotype A. Yuan-Ping Pang, Jon Davis, Shaohua Wang, Jewn Giew Park, Madhusoodana P. Nambiar, J. Schmidt, and Charles B. Millard, PLoS ONE, 5(4): e10129 (2010).
  • Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design. Yuan-Ping Pang, Anuradha Vummenthala, Rajesh K. Mishra, Jewn Giew Park, Shaohua Wang, Jon Davis, Charles B. Millard, and James J. Schmidt, PLoS ONE, 4(11): e7730 (2009).
  • Selective and Irreversible Inhibitors of Mosquito Acetylcholinesterases for Controlling Malaria and Other Mosquito-Borne Diseases. Yuan-Ping Pang, Fredrik Ekström, Gregory A. Polsinelli, Yang Gao, Sandeep Rana, Duy H. Hua, Björn Andersson, Per Ola Andersson, Lei Peng, Sanjay K. Singh, Rajesh K. Mishra, Kun Yan Zhu, Ann M. Fallon, David W. Ragsdale, and Stephen Brimijoin, PLoS ONE, 4(8): e6851 (2009).
  • Structure of HI-6•Sarin-Acetylcholinesterase Determined by X-ray Crystallography and Molecular Dynamics Simulation: Reactivator Mechanism and Design. Fredrik Ekström, Andreas Hörnberg, Elisabet Artursson, Lars-Gunnar Hammarström, Gunter Schneider, and Yuan-Ping Pang, PLoS ONE, 4(6): e5957 (2009).
  • Selective and Irreversible Inhibitors of Aphid Acetylcholinesterases: Steps toward Human-Safe Insecticides. Yuan-Ping Pang, Sanjay K. Singh, Yang Gao, T. Leon Lassiter, Rajesh K. Mishra, Kun Yan Zhu, Stephen Brimijoin, PLoS ONE 4(2): e4349. doi:10.1371/journal.pone.0004349 (2009).
  • EUDOC on Blue Gene: Accelerating the Transfer of Drug Discoveries from Laboratory to Patient, Yuan-Ping Pang, Tim Mullins, Brent Swartz, Jeffrey McAllister, Brian Smith, Charles Archer, Roy Musselman, Amanda Peters, Brian Wallenfelt, Kurt Pinnow, IBM J. Res. Dev., 52, 69-81 (2008).
  • Convenient Synthesis of a Library of Discrete Hydroxamic Acids Using the Hydroxythiophenol (Marshall) Resin. Jinil Choi, Jewn Giew Park, and Yuan-Ping Pang, Tetrahedron Lett., 49, 1103-1106 (2008).
  • Normal-Mode-Analysis–Monitored Energy Minimization Procedure for Generating Small–Molecule Bound Conformations. Qi Wang and Yuan-Ping Pang, PLoS ONE, 2(10): e1025. doi:10.1371/journal.pone.0001025 (2007).
  • Preference of Small Molecules for Local Minimum Conformations When Binding to Proteins. Qi Wang and Yuan-Ping Pang, PLoS ONE, 2(9): e820. doi:10.1371/journal.pone.0000820 (2007).
  • Computer-aided Lead Optimization: Improved Small-Molecule Inhibitor of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A. Jing Tang, Jewn Giew Park, Charles B. Millard, James J. Schmidt, and Yuan-Ping Pang, PLoS ONE, 2(8): e761. doi:10.1371/journal.pone.0000761 (2007).
  • Accurate reproduction of 161 small-molecule crystal structures using the EUDOC program: expanding the use of EUDOC to supramolecular chemistry. Qi Wang and Yuan-Ping Pang, PLoS ONE, 2(6): e531. doi:10.1371/journal.pone.0000531 (2007).
  • Novel Nerve-Agent Antidote Design Based on Crystallographic and Mass Spectrometric Analyses of Tabun-Conjugated Acetylcholinesterase in Complex with Antidotes. Fredrik J. Ekström, Crister Åstot, and Yuan-Ping Pang, Clinical Pharmacology & Therapeutics, 82, 282-293 (2007).
  • Novel Acetylcholinesterase Target Site for Malaria Mosquito Control. Yuan-Ping Pang, PLoS ONE, 1(1): e58. doi:10.1371/journal.pone.0000058 (2006)
  • In Silico Drug Discovery: Solving the "Target-Rich and Lead-Poor" Imbalance Using the Genome-to-Drug-Lead Paradigm, Yuan-Ping Pang, Clinical Pharmacology & Therapeutics, 81, 30-34 (2007).
  • Species Marker for Developing Novel and Safe Pesticides, Yuan-Ping Pang, Bioorg. Med. Chem. Lett., 17, 197-199 (2007)
  • Crystal Structures of Acetylcholinesterase in Complex with HI-6, Ortho-7 and Obidoxime: Structural Basis for Differences in the Ability to Reactivate Tabun Conjugates. Fredrik Ekström, Yuan-Ping Pang, Malin Boman, Elisabet Artursson, Christine Akfur, and Susanne Lundberg, Biochemical Pharmacology, 72, 597-607, (2006).
  • Bis-Imidazoles as Molecular Probes for Peripheral Sites of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A. Isidro Merino, Jason D. Thompson, Charles B. Millard, James J. Schmidt, and Yuan-Ping Pang, Bioorg. Med. Chem., 14, 3583-3591 (2006).
  • From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus. Andrea J. Dooley, Nice Shindo, Barbara Taggart, Jewn-Giew Park and Yuan-Ping Pang, Bioorg. Med. Chem. Lett., 16, 830-833 (2006).
  • Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. JG Park, PC Sill, EF Makiyi, AT Garcia-Sosa, CB Millard, JJ Schmidt, YP Pang, Bioorg. Med. Chem., 14, 395-408 (2006).
  • A potent and Selective Tacrine Analog - Biomembrane Permeation and Physicochemical Characterization. George A. Patani, Yuan-Ping Pang, Yie W. Chien, Pharm. Dev. Technol., 10, 525-538 (2005).
  • Novel dimeric acetylcholinesterase inhibitor bis(7)-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors. WM Li, RB Pi, HHN Chan, HJ Fu, NTK Lee, HW Tsang, YM Pu, DC Chang, CY Li, JL Luo, KM Xiong, ZW Li, H Xue, PR Carlier, YP Pang, KWK Tsim, MT Li, YF Han, J. Biol. Chem., 280, 18179-18188 (2005).
  • Inhibition by bis(7)-tacrine of 5-HT-activated current in rat TG neurons. JL Luo, J Zhang, BC Guan, YP Pang, YF Han, ZW Li, Neuroreport, 15, 1335-1338 (2004).
  • Nonbonded Bivalence Approach to Cell-Permeable Molecules That Target DNA Sequences. Yuan-Ping Pang, Bioorg. Med. Chem., 12, 3063-3068 (2004).
  • Improved Loading and cleavage Methods for Solid-Phase Synthesis Using Chlorotrityl Resins: Synthesis and Testing of a Library of 144 Discrete Chemicals as Potential Farnesyltransferase Inhibitors. Jewn Giew Park, Kevin J. Langenwalter, Carolyn A. Weinbaum, Patrick J. Casey, Yuan-Ping Pang, J. Comb. Chem., 6, 407-413 (2004).
  • Cholinesterase Reactivation in Vivo with a Novel Bis-Oxime Optimized by Computer-Aided Design. PI Hammond, C. Kern, F. Hong, TM Kollmeyer, Y-P Pang, and S Brimijoin, J. Pharmaco. Exp. Ther., 307, 190-196 (2003).
  • Rational Design of Alkylene-Linked Bis-Pyridiniumaldoximes as Improved Acetylcholinesterase Reactivators. Yuan-Ping Pang, Thomas M. Kollmeyer, Feng Hong, Jong-Cheol Lee, Pamela I. Hammond, Sharie P. Haugabouk, and Stephen Brimijoin, Chem. Biol. 10, 491-502 (2003).
  • Re-Engineering Butyrylcholinesterase as a Cocaine Hydrolase. Hong Sun, Yuan-Ping Pang, Oksana Lockridge, and Stephen Brimijoin, Mol. Pharmacol., 62, 220-224 (2002).
  • Theoretical 3D Model of Histamine N-Methyltransferase: Insights into the Effects of a Genetic Polymorphism on Enzymatic Activity and Thermal Stability. Y.-P. Pang, X.-E. Zheng, and R. M. Weinshilboum, Biochem. Bioph. Res. Commun., 287, 204-208 (2001).
  • Discovery of a New Inhibitor Lead of Adenovirus Proteinase: Steps Toward Selective, Irreversible Inhibitors of Cysteine Proteinases. Yuan-Ping Pang, Kun Xu, Thomas M. Kollmeyer, Emanuele Perola, William J. McGrath, Dave T. Green, and Walter F. Mangel, FEBS Lett., 502, 93-97 (2001).
  • Successful Molecular Dynamics Simulation of Two Zinc Complexes Bridged by a Hydroxide in Phosphotriesterase Using the Cationic Dummy Atom Method. Yuan-Ping Pang, Proteins, 45, 183-189 (2001).
  • EUDOC: A Computer Program for Identification of Drug Interaction Sites in Macromolecules and Drug Leads from Chemical Databases. Yuan-Ping Pang, Emanuele Perola, Kun Xu, and Franklyn G. Prendergast, J. Comp. Chem., 22, 1750-1771 (2001).
  • Predicted Michaelis-Menten Complexes of Cocaine-Butyrylcholinesterase: Engineering Effective Butyrylcholinesterase Mutants for Cocaine Detoxication. Hong Sun, Jamal El Yazal, Oksana Lockridge, Lawrence M Schopfer, Stephen Brimijoin, and Yuan-Ping Pang, J. Biol. Chem., 276, 9330-9336 (2001).
  • Protonation States of the Chromophore of Denatured Green Fluorescent Proteins Predicted by ab Initio Calculation. Jamal El Yazal, Franklyn G. Prendergast, David E. Shaw, and Yuan-Ping Pang, J. Am. Chem. Soc., 122, 11411-11415 (2000).
  • Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine. Xiao Qiu Xiao, Nelson Tze-Kin Lee, Paul R. Carlier, Yuan-Ping Pang and Yi Fan Han, Neuroscience Letters, 290, 197-200 (2000).
  • Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis(7)-tacrine, a novel anti-Alzheimer's agent. Yi-Fan Han, Dong-Cheng Wu, Xiao-Qiu Xiao, Priscilla M. Y. Chen, Wilson Chung, Nelson T. K. Lee, Yuan-Ping Pang and Paul R. Carlier, Neuroscience Letters, 288, 95-98 (2000).
  • Proton Dissociation Energies of Zinc-Coordinated Hydroxamic Acids and Their Relative Affinities for Zinc: Insights into Design of Zinc Proteinase Inhibitors. Jamal El Yazal and Yuan-Ping Pang, J. Phys. Chem. B, 104, 6499-6504 (2000).
  • Zinc's Affect on Proton Transfer between Imidazole and Acetate Predicted by ab Initio Calculations. Jamal El Yazal, Rachel R. Roe, and Yuan-Ping Pang, J. Phys. Chem. B, 104, 6662-6667 (2000).
  • Dimerization of an Inactive Fragment of Huperzine A Produces a Drug with Twice the Potency of the Natural Product. Paul R. Carlier, Da-Ming Du, Yi-Fan Han, Jing Liu, Emanuele Perola, Ian D. Williams, and Yuan-Ping Pang, Angew. Chem. Int. Ed. Engl., 39, 1775-1777 (2000).
  • Bis(7)-Tacrine, a Novel AChE Inhibitor, Reverses AF64A-Induced Spatial Memory Impairment in Rats. Jing Liu, Wing-Lok Ho, Nelson Tze-Kin Lee, Paul R Carlier, Yuan-Ping Pang, Yi-Fan Han, Neuroscience Letters. 282, 165-168 (2000).
  • Successful Virtual Screening of a Chemical Database for Farnesyltransferase Inhibitor Leads. Emanuele Perola, Kun Xu, Thomas M. Kollmeyer, Scott H. Kaufmann, Franklyn G. Prendergast, and Yuan-Ping Pang, J. Med. Chem., 43, 401-408 (2000).
  • Novel Zinc Protein Molecular Dynamics Simulations: Steps Toward Antiangiogenesis for Cancer Treatment. Yuan-Ping Pang, J. Mol. Model., 5, 196-202 (1999).
  • Ab Initio Calculations of Proton Dissociation Energies of Zinc Ligands: Hypothesis of Imidazolate as Zinc Ligand in Proteins. Jamal El Yazal and Yuan-Ping Pang, J. Phys. Chem. B, 103, 8773-8779 (1999).
  • Ab Initio Calculations of Proton Dissociation Energies of Zinc Ligands: Hypothesis of Imidazolate as Zinc Ligand in Proteins. Jamal El Yazal and Yuan-Ping Pang, J. Phys. Chem. B, 103, 8773-8779 (1999).
  • Attenuation of scopolamine-induced deficits in navigational memory performance in rats by bis(7)-tacrine, a novel dimeric AChE inhibitor. H. Wang, P. R. Carlier, W.L. Ho, N.T.K. Lee, Y.-P. Pang, and Y.F. Han, Acta Pharmacologica Sinica 20, 211-217 (1999).
  • Effects of bis(7)-THA, a novel promising Alzheimer's therapeutic, on rat brain acetylcholinesterase. H. Wang, P. R. Carlier, W.-L. Ho, N. T. K. Lee, C. R. L. Li, Y.-P. Pang and Y.-F. Han, Neuroreport, 10, 789-793 (1999).
  • Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABAA receptor antagonist. C.Y. Li, H. Wang, H. Xue, P. R. Carlier, K. M. Hui, Y.-P. Pang, Z. W. Li and Y.-F. Han, Neuroreport, 10, 795-800 (1999).
  • Computational and Experimental Studies of (2,2)-Bis(indol-1-yl-methyl)acetate Suggest the Importance of the Hydrophobic Effect in Aromatic Stacking Interactions. Y.-P. Pang, J. Miller, and P. A. Kollman, J. Am. Chem. Soc., 121, 1717-1725 (1999).
  • Atomic Levers Control Pyranose Ring Conformations. P. E. Marszalek, Y.-P. Pang, H. Li, J. El Yazal, A. F. Oberhauser, and J. M. Fernandez, Proc. Natl. Acad. Sci. USA 96, 7894-7898 (1999).
  • Polysaccharide Elasticity Governed by Chair-Boat Transition of the Glucopyranose Ring. Piotr E. Marszalek, Andres F. Oberhauser, Yuan-Ping Pang, and Julio M. Fernandez, Nature, 396, 661-664 (1998).
  • Highly Potent, Selective, and Low-cost bis-Tetrahydroaminacrine Inhibitors of Acetylcholinesterase: Steps Toward Novel Drugs for Treating Alzheimer's Disease. Yuan-Ping Pang, Polly Quiram, Tanya Jelacic, Feng Hong, and Stephen Brimijoin, rapid communication, J. Biol. Chem., 271, 23646-23649 (1996).
  • Proposed Ligand Binding Site of the Transmembrane Neurotensin Receptor. Yuan-Ping Pang, Bernadette Cusack, Karen Groshan, and Elliott Richelson, J. Biol. Chem., 271, 15060-15068 (1996).
  • Applications of Free Energy Derivatives to Analog Design. Yuan-Ping Pang and Peter A. Kollman, Perspectives in Drug Discovery and Design, 3, 106-122 (1995).
  • Prediction of 1-Benzyl-4-[(5,6-dimethoxy-1-indanone-2-yl)methyl]piperidine's Binding Site in Acetylcholinesterase by Docking Studies with the SYSDOC Program. Yuan-Ping Pang and Alan P. Kozikowski, J. Comput.-Aided Mol. Design, 8, 682-693 (1994).
  • Prediction of Huperzine A's Binding Sites in Acetylcholinesterase by Docking Studies. Yuan-Ping Pang and Alan Kozikowski, J. Comput.-Aided Mol. Design, 8, 669-681 (1994).
  • Rational Design of Novel Neurotensin Mimetics: Discovery of a Pharmacologically Unprecedented Agent Exhibiting Concentration-Dependent Dual Effects as Antagonist and Full Agonist. Yuan-Ping Pang, Javid Zaidi, Alan P. Kozikowski, Bernadette Cusack, and Elliott Richelson, J. Comput.-Aided Mol. Design, 8, 433-440 (1994).
  • A Route to Optically Pure (-)-Huperzine A; Molecular Modeling and In Vitro Pharmacology. Fumio Yamada, Alan P. Kozikowski, E. R. Reddy, Yuan-Ping Pang, Jacqueline H. Miller, and Michael McKinney, J. Am. Chem. Soc., 113, 4695-4696 (1991).
  • Synthesis of Methoxy and Hydroxy Analogues of 1,2,3,4,4a,9a-Hexahydro-4a-fluorenamine - Rigid Phencyclidine Analogues as Probes of PCP Receptor Topography. Yuan-Ping Pang and Alan P. Kozikowski, J. Org. Chem., 56, 4499-4508 (1991).
  • Structural Determinants of Affinity for the PCP Binding Site of the NMDA Receptor Complex: Discovery of a Rigid PCP Analogue of High Binding Affinity. Alan P. Kozikowski and Yuan-Ping Pang, Mol. Pharmacol., 37, 352-357 (1990).